MMP1 and non-small cell lung carcinoma: We then combined the upregulated genes of GSE19188 and GSE80344 datasets to narrow down the potential genes conferring erlotinib resistance in NSCLC and found that the expression of MMP1 was markedly increased in both datasets (Fig. 3a).